| scholarly article | Q13442814 |
| P2093 | author name string | Lipworth BJ | |
| Jackson CM | |||
| Allam C | |||
| Grove A | |||
| McFarlane LC | |||
| McPhate G | |||
| P2860 | cites work | Assessment of systemic effects of inhaled glucocorticosteroids: comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover | Q70212935 |
| Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man | Q70478641 | ||
| A sensitive radioimmunoassay, incorporating solid-phase extraction, for fluticasone 17-propionate in plasma | Q70481385 | ||
| Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid | Q72054490 | ||
| Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects | Q72330237 | ||
| A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group | Q72853175 | ||
| Bone turnover during high dose inhaled corticosteroid treatment | Q28316066 | ||
| The influence of orally deposited budesonide on the systemic availability of budesonide after inhalation from a Turbuhaler | Q34345721 | ||
| Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler | Q36253525 | ||
| Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction | Q36280545 | ||
| Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group | Q36285443 | ||
| Clinical pharmacology of corticosteroids in bronchial asthma | Q40866746 | ||
| The human pharmacology of fluticasone propionate | Q44383011 | ||
| Screening for hypothalamo-pituitary-adrenal axis suppression in asthmatics taking high dose inhaled corticosteroids | Q48631511 | ||
| Effect of high-dose inhaled budesonide on calcium and phosphate metabolism and the risk of osteoporosis. | Q51625098 | ||
| Effects of dose and dosing schedule of inhaled budesonide on bone turnover | Q68011572 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fluticasone propionate | Q8564098 |
| P304 | page(s) | 527-532 | |
| P577 | publication date | 1994-12-01 | |
| P1433 | published in | British Journal of Clinical Pharmacology | Q176044 |
| P1476 | title | A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects | |
| P478 | volume | 38 |
| Q77755098 | A comparison of multiple doses of fluticasone propionate and beclomethasone dipropionate in subjects with persistent asthma |
| Q41559651 | A comparison of the efficacy and safety of inhaled corticosteroids in asthma |
| Q33487588 | A sensitive method for the quantification of fluticasone propionate in human plasma by high-performance liquid chromatography/atmospheric pressure chemical ionisation mass spectrometry |
| Q31370518 | A study comparing the clinical pharmacokinetics, pharmacodynamics, and tolerability of triamcinolone acetonide HFA-134a metered-dose inhaler and budesonide dry-powder inhaler following inhalation administration |
| Q53995280 | An assessment of the systemic effects of single and repeated doses of inhaled fluticasone propionate and inhaled budesonide in healthy volunteers. |
| Q53903346 | Body composition and growth in asthmatic children treated with inhaled steroids. |
| Q33976334 | Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group |
| Q74605794 | Clinical adverse effects of inhaled corticosteroids: results of a questionnaire survey of asthma specialists |
| Q74369770 | Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less |
| Q33775866 | Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients |
| Q41718750 | Comparison of inhaled corticosteroids |
| Q41333143 | Dose-response of inhaled drugs in asthma. An update |
| Q48231741 | Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma |
| Q41728966 | Efficacy and safety of inhaled corticosteroids. New developments |
| Q33851527 | Inhaled and nasal corticosteroids: safety aspects |
| Q41104921 | Inhaled glucocorticoids: new developments relevant to updating of the asthma management guidelines |
| Q42419173 | New perspectives on inhaled drug delivery and systemic bioactivity |
| Q41068716 | Optimizing inhaled drug delivery in patients with asthma |
| Q41752126 | Relative safety and efficacy of inhaled corticosteroids |
| Q43201913 | Systemic effects of glucocorticoids‐‐a response [comment] |
| Q49083717 | Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma |
| Q41151318 | The role of corticosteroids in respiratory diseases of children |
| Q43407227 | Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function |
| Q42066080 | Treatment of isolated gastric Crohn's disease with inhaled corticosteroids |
Search more.